Postpartum thyroiditis screening: Difference between revisions
Jump to navigation
Jump to search
Sunny Kumar (talk | contribs) |
|||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
*There is insufficient evidence to recommend routine screening for PPT. | *There is insufficient evidence to recommend routine screening for PPT. | ||
==Screening== | ==Screening== | ||
Revision as of 13:34, 12 October 2017
|
Postpartum thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postpartum thyroiditis screening On the Web |
|
American Roentgen Ray Society Images of Postpartum thyroiditis screening |
|
Risk calculators and risk factors for Postpartum thyroiditis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
- There is insufficient evidence to recommend routine screening for PPT.
Screening
- There is insufficient evidence to recommend routine screening for PPT.
- According to the Endocrinology and Metabolism Clinics of North America[1] screening for postpartum thyroiditis in first trimester by measuring anti-TPO antibodies should be limited to every high risk pregnant women with:
- Type 1 DM.
- History of postpartum thyroiditis.
- Any patient with high risk should be followed with TSH levels every 6th and 9th postpartum period.[2]
- According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women.[3]
References
- ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
- ↑ Keely EJ (2011). "Postpartum thyroiditis: an autoimmune thyroid disorder which predicts future thyroid health". Obstet Med. 4 (1): 7–11. doi:10.1258/om.2010.100041. PMC 4989649. PMID 27579088.
- ↑ Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988). "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction". Am J Obstet Gynecol. 159 (1): 203–9. PMID 3394739.